Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer

Cancer Cell · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles